Allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning regimen: Outcomes of patients admitted to intensive care unit

Journal of Critical Care

Volumn 30, Issue 5, 2015, Pages 1107-1113

  Mokart, Djamel ^a,b   Granata, Angela ^a   Crocchiolo, Roberto ^a   Sannini, Antoine ^a   Chow Chine, Laurent ^a   Brun, Jean Paul ^a   Bisbal, Magali ^a   Faucher, Marion ^a   Faucher, Catherine ^a   Blache, Jean Louis ^a   Castagna, Luca ^a   Fürst, Sabine ^a   Blaise, Didier ^a  

^a INSTITUT PAOLI CALMETTES   (France)

^b GRRR OH Groupe de Recherche en Réanimation Respiratoire du patient d Onco Hématologie   (France)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Hematology patients; Intensive care unit; Mechanical ventilation; Prognosis; Reduced intensity conditioning regimen

Indexed keywords

BILIRUBIN;

ACUTE LEUKEMIA; ACUTE RESPIRATORY FAILURE; ADULT; AGE DISTRIBUTION; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ARTIFICIAL VENTILATION; BILIRUBIN BLOOD LEVEL; CARDIOGENIC SHOCK; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEMATOLOGIC DISEASE; HEMODYNAMIC STRESS; HEMORRHAGIC SHOCK; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; HYPOVOLEMIC SHOCK; INTENSIVE CARE; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT CARE; PROGNOSIS; REDUCED INTENSITY CONDITIONING; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEPSIS; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; SURVIVAL PREDICTION; SURVIVAL RATE; SURVIVAL TIME; TACHYCARDIA; AUTOTRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL MORTALITY; HOSPITALIZATION; NONINVASIVE VENTILATION; PROCEDURES; STATISTICS AND NUMERICAL DATA; TRANSPLANTATION CONDITIONING;

ADULT; CRITICAL CARE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; NONINVASIVE VENTILATION; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS;

EID: 84941314360     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2015.06.020     Document Type: Article

References (38)

1. Gooley T.A., Chien J.W., Pergam S.A., Hingorani S., Sorror M.L., Boeckh M., et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 2010, 363:2091-2101.
2. Pene F., Aubron C., Azoulay E., Blot F., Thiery G., Raynard B., et al. Outcome of critically ill allogeneic hematopoietic stem-cell transplantation recipients: a reappraisal of indications for organ failure supports. J Clin Oncol 2006, 24:643-649.
3. Rubenfeld G.D., Crawford S.W. Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines. Ann Intern Med 1996, 125:625-633.
4. Huynh T.N., Weigt S.S., Belperio J.A., Territo M., Keane M.P. Outcome and prognostic indicators of patients with hematopoietic stem cell transplants admitted to the intensive care unit. J Transplant 2009, 2009:917294.
5. Price K.J., Thall P.F., Kish S.K., Shannon V.R., Andersson B.S. Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit. Am J Respir Crit Care Med 1998, 158:876-884.
6. Soubani A.O., Kseibi E., Bander J.J., Klein J.L., Khanchandani G., Ahmed H.P., et al. Outcome and prognostic factors of hematopoietic stem cell transplantation recipients admitted to a medical ICU. Chest 2004, 126:1604-1611.
7. Bacigalupo A., Ballen K., Rizzo D., Giralt S., Lazarus H., Ho V., et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009, 15:1628-1633.
8. Kassim A.A., Chinratanalab W., Ferrara J.L., Mineishi S. Reduced-intensity allogeneic hematopoietic stem cell transplantation for acute leukemias: "what is the best recipe?". Bone Marrow Transplant 2005, 36:565-574.
9. Blaise D., Farnault L., Faucher C., Marchetti N., Furst S., El C.J., et al. Reduced-intensity conditioning with Fludarabin, oral Busulfan, and thymoglobulin allows long-term disease control and low transplant-related mortality in patients with hematological malignancies. Exp Hematol 2010, 38:1241-1250.
10. Blaise D., Tabrizi R., Boher J.M., Le Corroller-Soriano A.G., Bay J.O., Fegueux N., et al. Randomized study of 2 reduced-intensity conditioning strategies for human leukocyte antigen-matched, related allogeneic peripheral blood stem cell transplantation: prospective clinical and socioeconomic evaluation. Cancer 2013, 119:602-611.
11. Crocchiolo R., Esterni B., Castagna L., Furst S., El-Cheikh J., Devillier R., et al. Two days of antithymocyte globulin are associated with a reduced incidence of acute and chronic graft-versus-host disease in reduced-intensity conditioning transplantation for hematologic diseases. Cancer 2013, 119:986-992.
12. Devillier R., Crocchiolo R., Castagna L., Furst S., El C.J., Faucher C., et al. The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT. Bone Marrow Transplant 2012, 47:639-645.
13. Azoulay E., Mokart D., Pene F., Lambert J., Kouatchet A., Mayaux J., et al. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium-a Groupe de Recherche Respiratoire en Reanimation Onco-Hematologique study. J Clin Oncol 2013, 31:2810-2818.
14. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013, 39:165-228.
15. Gratwohl A., Hermans J., Goldman J.M., Arcese W., Carreras E., Devergie A., et al. Risk assessment for patients with chronic myeloid leukaemia before allogeneic blood or marrow transplantation. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation. Lancet 1998, 352:1087-1092.
16. Sorror M.L., Maris M.B., Storb R., Baron F., Sandmaier B.M., Maloney D.G., et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005, 106:2912-2919.
17. Le Gall J.R., Lemeshow S., Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963.
18. Bach P.B., Schrag D., Nierman D.M., Horak D., White P., Young J.W., et al. Identification of poor prognostic features among patients requiring mechanical ventilation after hematopoietic stem cell transplantation. Blood 2001, 98:3234-3240.
19. Groeger J.S., White P., Nierman D.M., Glassman J., Shi W., Horak D., et al. Outcome for cancer patients requiring mechanical ventilation. J Clin Oncol 1999, 17:991-997.
20. Kress J.P., Christenson J., Pohlman A.S., Linkin D.R., Hall J.B. Outcomes of critically ill cancer patients in a university hospital setting. Am J Respir Crit Care Med 1999, 160:1957-1961.
21. Lengline E., Chevret S., Moreau A.S., Pene F., Blot F., Bourhis J.H., et al. Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 2015, 50(6):840-845.
22. Mokart D., Lambert J., Schnell D., Fouche L., Rabbat A., Kouatchet A., et al. Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure. Leuk Lymphoma 2013, 54:1724-1729.
23. Mokart D., Pastores S.M., Darmon M. Has survival increased in cancer patients admitted to the ICU? Yes. Intensive Care Med 2014, 40:1570-1572.
24. Afessa B., Tefferi A., Dunn W.F., Litzow M.R., Peters S.G. Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients. Crit Care Med 2003, 31:1715-1721.
25. Townsend W.M., Holroyd A., Pearce R., Mackinnon S., Naik P., Goldstone A.H., et al. Improved intensive care unit survival for critically ill allogeneic haematopoietic stem cell transplant recipients following reduced intensity conditioning. Br J Haematol 2013, 161:578-586.
26. Bayraktar U.D., Shpall E.J., Liu P., Ciurea S.O., Rondon G., de L.M., et al. Hematopoietic cell transplantation-specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit. J Clin Oncol 2013, 31:4207-4214.
27. Fukuda T., Boeckh M., Carter R.A., Sandmaier B.M., Maris M.B., Maloney D.G., et al. Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning. Blood 2003, 102:827-833.
28. Hakki M., Riddell S.R., Storek J., Carter R.A., Stevens-Ayers T., Sudour P., et al. Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation. Blood 2003, 102:3060-3067.
29. Marr K.A., Patterson T., Denning D. Aspergillosis. Pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am 2002, 16:875-894.
30. Narimatsu H., Matsumura T., Kami M., Miyakoshi S., Kusumi E., Takagi S., et al. Bloodstream infection after umbilical cord blood transplantation using reduced-intensity stem cell transplantation for adult patients. Biol Blood Marrow Transplant 2005, 11:429-436.
31. Freudenberger T.D., Madtes D.K., Curtis J.R., Cummings P., Storer B.E., Hackman R.C. Association between acute and chronic graft-versus-host disease and bronchiolitis obliterans organizing pneumonia in recipients of hematopoietic stem cell transplants. Blood 2003, 102:3822-3828.
32. Hingorani S.R., Seidel K., Lindner A., Aneja T., Schoch G., McDonald G. Albuminuria in hematopoietic cell transplantation patients: prevalence, clinical associations, and impact on survival. Biol Blood Marrow Transplant 2008, 14:1365-1372.
33. Pene F., Percheron S., Lemiale V., Viallon V., Claessens Y.E., Marque S., et al. Temporal changes in management and outcome of septic shock in patients with malignancies in the intensive care unit. Crit Care Med 2008, 36:690-696.
34. Zuber B., Tran T.C., Aegerter P., Grimaldi D., Charpentier J., Guidet B., et al. Impact of case volume on survival of septic shock in patients with malignancies. Crit Care Med 2012, 40:55-62.
35. Azoulay E., Mokart D., Lambert J., Lemiale V., Rabbat A., Kouatchet A., et al. Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med 2010, 182:1038-1046.
36. Azoulay E., Lemiale V. Non-invasive mechanical ventilation in hematology patients with hypoxemic acute respiratory failure: a false belief?. Bone Marrow Transplant 2012, 47:469-472.
37. Saillard C., Mokart D., Lemiale V., Azoulay E. Mechanical ventilation in cancer patients. Minerva Anestesiol 2013, 80:712-725.
38. Ljungman P., Bregni M., Brune M., Cornelissen J., de Witte T., Dini G., et al. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe 2009. Bone Marrow Transplant 2010, 45:219-234.